您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2015, Vol. 53 ›› Issue (11): 73-76.doi: 10.6040/j.issn.1671-7554.0.2015.312

• 临床医学 • 上一篇    下一篇

妇科门诊女性人乳头瘤病毒感染型别分布特征及临床分析

李晨1, 程玉峰1, 李爱禄2   

  1. 1. 山东大学齐鲁医院放疗科, 山东 济南 250012;
    2. 福建医科大学附属泉州第一医院妇产科, 福建 泉州 362000
  • 收稿日期:2015-03-23 出版日期:2015-11-10 发布日期:2015-11-10
  • 通讯作者: 程玉峰.E-mail:qlcyfsdu@163.com E-mail:qlcyfsdu@163.com

Clinical analysis and type distribution of human papilloma virus among gynecologic outpatients

LI Chen1, CHENG Yufeng1, LI Ailu2   

  1. 1. Department of Radiation Oncology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;
    2. Department of Obstetrics and Gynecology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou 362000, Fujian, China
  • Received:2015-03-23 Online:2015-11-10 Published:2015-11-10

摘要: 目的 分析妇科门诊女性人乳头瘤病毒(HPV)感染率、HPV型别分布及不同人群、不同年龄组HPV感染特征,探讨其与宫颈病变的关系.方法 采用导流杂交基因芯片法对妇科门诊5 869名女性进行HPV分型检测.结果 5 869例样本中,HPV总感染率为23.6%,HPV高危型检出率占19.6%,低危型为6.7%,HPV感染率较高型别依次为HPV16、52、11、58、6、18、53、33;1385例HPV阳性中,存在HPV亚型单一感染(72.1%)、双重感染(21.3%)及三重以上感染(6.6%).宫颈癌患者HPV感染率(91.7%)明显高于宫颈炎患者(χ2=207.426, P<0.001)和健康体检者(χ2=252.211, P<0.001),宫颈癌患者HPV感染率较高亚型为HPV16、18、31、33、58、45.不同年龄女性HPV的感染率差异有统计学意义(χ2=36.486, P<0.01),≤25岁HPV感染率最高(32.5%),其次是>50岁(28.4%).结论 妇科门诊女性HPV感染以高危型为主,低危型为次,同时存在HPV高、低危亚型混合感染以及多重感染,HPV感染型别分布具有人群特点和地域差异;不同人群HPV感染率存在差异,宫颈癌患者HPV感染率最高,除HPV16、18外,其他HPV高危亚型也与宫颈病变及宫颈癌密切相关;≤25岁和>50岁是HPV感染高危人群.

关键词: 人乳头瘤病毒, 病毒感染, 基因芯片, 宫颈肿瘤

Abstract: Objective To explore the infection rate and characteristics of human papilloma virus (HPV) among gynecologic outpatients, distribution of HPV types, and the relationship between HPV and cervical neoplasms. Methods Flow-through hybridization and gene chip ttechnique was employed to detect HPV genotypes of 5 869 gynecologic outpatients. Results The total infection rate was 23.6%, the detection rate of HR-HPV and LR-HPV was 19.6% and 6.7%, respectively. The most common type of HPV was HPV16, followed by 52, 11, 58, 6, 18, 53 and 33. Of the 1,385 HPV cases, 72.1% acquired single subtype of HPV, 21.3% had two different subtypes, and 6.6% had more than three different subtypes. HPV infection rate in patients with cervical cancer (91.7%) was significantly higher than that in patients with cervicitis (χ2=207.426, P<0.001) and healthy controls (χ2=252.211, P<0.001). HPV16,18, 31, 33, 58 and 45 were most commonly found in patients with cervical cancer. HPV infection rate was significant (χ2=36.486, P<0.01) in different age groups, the highest (32.5%) was in women under 25 years old, followed by 28.4% in women above 50 years old. Conclusion Among gynecologic HPV outpatients, most were infected with HR-HPV, some with LR-HPV, and a few with both HR- HPV and LR-HPV or with multiple HPV. There were obviousregional differences and characteristics of HPV type distribution in different population groups. The highest rate of HPV infection was in patients with cervical cancer. HPV 16, 18, and other HR- HPV were found to be closely related with cervical lesions and cervical cancer. Women under 25 and above 50 years old were high-risk groups.

Key words: Cervical neoplasms, Viral infection, Human Papillioma Virus, Gene chips

中图分类号: 

  • R737.33
[1] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108.
[2] Sukasem C, Pairoj W, Saekang N, et al. Molecular epidemiology of human papillomavirus genotype in women with high-grade squamous intraepithelial lesion and cervical cancer: will a quadrivalent vaccine be necessary in Thailand?[J]. J Med Virol, 2011, 83(1): 119-126.
[3] Li J, Xu H, Chen Y, et al. Laparoscopic nerve-sparing radical parametrectomy for occult early-stage invasive cervical cancer after simple hysterectomy[J]. Int J Gynecol Cancer, 2012, 22(8): 1383-1388.
[4] Marnitz S, Kohler C, Affonso RJ, et al. Validity of laparoscopic staging to avoid adjuvant chemoradiation following radical surgery in patients with early cervical cancer[J]. Oncology, 2012, 83(6): 346-353.
[5] Tergas AI, Fader AN. Laparoendoscopic single-site surgery (LESS) radical hysterectomy for the treatment of early stage cervical cancer[J]. Gynecol Oncol, 2013, 129(1): 241-243.
[6] Atilgan R, Celik A, Boztosun A, et al. Evaluation of cervical cytological abnormalities in turkish population[J]. Indian J Pathol Microbiol, 2012, 55(1): 52-55.
[7] Guo YL, You K, Qiao J, et al. Natural history of infections with high-risk HPV in Chinese women with abnormal cervical cytology findings at baseline[J]. Int J Gynaecol Obstet, 2010, 110(2): 137-140.
[8] Arbyn M, Castellsague X, de Sanjose S, et al. Worldwide burden of cervical cancer in 2008[J]. Ann Oncol, 2011, 22(12): 2675-2686.
[9] Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer[J]. N Engl J Med, 2003, 348(6): 518-527.
[10] Chan PK, Chang AR, Cheung JL, et al. Determinants of cervical human papillomavirus infection: differences between high- and low-oncogenic risk types[J]. J Infect Dis, 2002, 185(1): 28-35.
[11] 张东红, 林美珊. 人乳头瘤病毒在国人宫颈病变中感染及型别分布特征的Meta分析[J]. 中国全科医学, 2010, 13(4): 1287-1290. ZHANG Donghong, LIN Meishan. Meta-analysis of human papillomavirus (HPV) prevalence and type distribution in cervical lesions in Chinese population[J]. Chinese General Practice, 2010, 13(4): 1287-1290.
[12] 陈红香. 新疆维吾尔族妇女人乳头瘤病毒测定与宫颈癌及癌前病变关系研究[J]. 中国医师杂志, 2010, 12(9): 1259-1260.
[13] Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis[J]. Br J Cancer, 2003, 88(1): 63-73.
[14] Clavel C, Masure M, Bory JP, et al. Hybrid capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women[J]. Br J Cancer, 1999, 80(9): 1306-1311.
[15] 杜辉, 吴瑞芳, 汤惠茹, 等. 深圳市成年女性生殖道高危型人乳头瘤病毒感染与宫颈癌患病调查[J]. 中华流行病学杂志, 2012, 33(8): 799-802 DU Hui, WU Ruifang, TANG Huiru, et al. Investigation on the prevalence of high risk human papillomavirus and cervical cancer among adult women, in Shenzhen[J]. Chinese Journal of Epidemiology, 2012, 33(8): 799-802.
[16] Lee SA, Kang D, Seo SS, et al. Multiple HPV infection in cervical cancer screened by HPVDNAChip[J]. Cancer Lett, 2003, 198(2): 187-192.
[1] 刘京康,杨建勇,孟丽华,姜洁. 血清miR-17-92簇在HPV阳性宫颈癌中的早期诊断价值[J]. 山东大学学报(医学版), 2017, 55(5): 86-90.
[2] 王遥,崔国英,王飞,李长忠. 人类白细胞抗原-E在宫颈癌中的表达及意义[J]. 山东大学学报(医学版), 2016, 54(9): 59-63.
[3] 王雅芬,杨勇霞,刘娅,马德美,朱琳. 宫颈细胞学阴性且高危型人乳头瘤病毒阳性人群的分流方法[J]. 山东大学学报(医学版), 2016, 54(8): 69-71.
[4] 张湛,许相丰,刘海东,王玮. MRI在宫颈癌T分期中的诊断价值[J]. 山东大学学报(医学版), 2016, 54(5): 70-73.
[5] 彭慧,何君梅,苏雪莲. 血清循环miR-375检测对宫颈癌早期诊断及术后监测的意义[J]. 山东大学学报(医学版), 2016, 54(3): 68-71.
[6] 杨晖,董蓉,薛慧,胡祖权,曾柱. 肝癌细胞对人成熟树突状细胞影响的基因芯片分析[J]. 山东大学学报(医学版), 2016, 54(1): 1-6.
[7] 田馨莉, 矫俊, 张腾, 马道新, 崔保霞. Th22细胞联合Th17细胞在宫颈癌外周血中的表达及意义[J]. 山东大学学报(医学版), 2015, 53(7): 43-47.
[8] 刘琼, 蒲业迪, 代广霞, 马家乐, 杨建霞, 李丽珍, 李颢, 王鲁群. 硼替佐米耐药多发性骨髓瘤细胞基因表达谱分析[J]. 山东大学学报(医学版), 2015, 53(6): 33-38.
[9] 刘亚飞, 张奇舒, 袁首道, 陈健行. HPV永生化细胞系与SiHa细胞系蛋白质表达差异的质谱分析[J]. 山东大学学报(医学版), 2015, 53(3): 22-26.
[10] 杜义江, 肖长义, 叶红, 汤桂成, 黎家华. CaSki细胞内HPVL1蛋白的表达[J]. 山东大学学报(医学版), 2015, 53(3): 17-21.
[11] 宗丽菊, 张友忠, 王颉, 吴淑霞, 刘洪丽, 张璐. 四甲基吡啶卟啉-光动力疗法对人宫颈永生化上皮H8细胞的作用[J]. 山东大学学报(医学版), 2015, 53(1): 21-26.
[12] 王颉, 张友忠, 冯进波, 刘洪丽, 宗丽菊. 慢病毒介导的hTERT-shRNA联合光动力治疗对宫颈癌细胞SiHa的影响[J]. 山东大学学报(医学版), 2015, 53(1): 27-33.
[13] 张演亮1,庄子荣2,朱琳1,梁婷婷1. 宫颈癌患者腹腔镜术后生存质量调查[J]. 山东大学学报(医学版), 2014, 52(6): 62-66.
[14] 刘平1,许俐2,孙源1,王志萍1. 妊娠期妇女宫颈人乳头瘤病毒感染率及型别分布[J]. 山东大学学报(医学版), 2014, 52(4): 107-112.
[15] 陶泽新, 杨静, 王海岩, 林小娟, 王素婷, 宋立志, 徐爱强. 2011年济南市某污水河中肠道病毒的分离鉴定与序列分析[J]. 山东大学学报(医学版), 2014, 52(11): 97-100.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!